PKM shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(5) HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor GrowthFrontiers in oncologyJanuary 1, 2020Wang L, Lu YF, Wang CS, Xie YX, Zhao YQ, Qian YC, Liu WT, Wang M, Jiang BH.

(6) Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic ReprogrammingMolecular & cellular proteomics : MCPAugust 1, 2018Li Q, Cao L, Tian Y, Zhang P, Ding C, Lu W, Jia C, Shao C, Liu W, Wang D, et al.

(7) The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucoseCell death & diseaseJanuary 26, 2018Li X, Deng S, Liu M, Jin Y, Zhu S, Deng S, Chen J, He C, Qin Q, Wang C, et al.

(9) PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathwaysMolecular medicine reportsMarch 1, 2015Feng J, Ma T, Ge Z, Lin J, Ding W, Chen H, Zhu W, Zhou S, Tan Y.

(10) Serine is a natural ligand and allosteric activator of pyruvate kinase M2NatureNovember 15, 2012Chaneton B, Hillmann P, Zheng L, Martin ACL, Maddocks ODK, Chokkathukalam A, Coyle JE, Jankevics A, Holding FP, Vousden KH, et al.

(11) The influence of ligand organization on the rate of uptake of gold nanoparticles by colorectal cancer cellsBiomaterialsDecember 1, 2011Lund T, Callaghan MF, Williams P, Turmaine M, Bachmann C, Rademacher T, Roitt IM, Bayford R.

(13) Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell lineJournal of cellular biochemistryMarch 1, 2010Li SL, Ye F, Cai WJ, Hu HD, Hu P, Ren H, Zhu FF, Zhang DZ.

PKM shRNA Plasmid (h)